Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-13

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a fixed-dose combination of diphenhydramine, pseudoephedrine, and dropropizine for non-productive cough and acute rhinitis was withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphenhydramine (diphenhydramine)
  • Dropropizine (dropropizine)
  • Pseudoephedrine (Pseudoephedrine)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Nasal Congestion, Cough | Phase 3 | Status: WITHDRAWN